Erin E. Burke
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
69
Citations
752
Est. group size
—
Recurring co-author estimate
Active years
30
Publishing since 1997
Erin E. Burke's work centers on surgical oncology, particularly melanoma and breast cancer management, including sentinel lymph node testing, gene expression profiling for cancer staging, and genetic testing for hereditary cancer risk. The research also touches on clinical trial development, care disparities, and reproductive health perceptions. Much of this work involves multicenter clinical trials and practical decision-making tools for surgeons treating cancer patients.
Publication output has fluctuated over the past decade with a dip around 2021-2023 followed by a notable increase in 2024-2025, suggesting renewed or growing activity in recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Gene Expression Profile–Based Test to Predict Melanoma Sentinel Node Status
JAMA Surgery · 2025
- Local management of second breast cancer event after primary breast conserving therapy: The patient's perspective
European Journal of Surgical Oncology · 2025
- A map of blood regulatory variation in South Africans enables GWAS interpretation
Nature Genetics · 2025
- Prospective multicenter evaluation of a clinicopathologic and gene expression profile test to predict sentinel node status in T1-T3 cN0 melanoma: updated MERLIN_001 trial
EJC Skin Cancer · 2025
- Development of a Novel Protocol for Germline Testing in Pancreatic Cancer
Annals of Surgical Oncology · 2024
- Gynecologic clear cell carcinoma and paraneoplastic cerebellar Degeneration: A literature review and case study
Gynecologic Oncology Reports · 2024
- ASO Visual Abstract: Development of a Novel Protocol for Germline Testing in Pancreatic Cancer
Annals of Surgical Oncology · 2024
- Treatment at an academic medical center eliminates survival disparities for Appalachian Kentuckians with pancreatic ductal adenocarcinoma
PubMed · 2024
- Non-designated preliminary resident success: how we do it
Global Surgical Education - Journal of the Association for Surgical Education · 2023
- Abstract CT053: Merlin_001: a prospective registry study of a primary melanoma gene-signature to predict sentinel node (SN) status and determine its prognostic value for more accurate staging of SN-negative melanoma patients
Cancer Research · 2023
- Completion Lymph Node Dissection for Melanoma Before and After the Multicenter Selective Lymphadenectomy Trial-II in the United States
Annals of Surgical Oncology · 2022
- The Development of Investigator-Initiated Clinical Trials in Surgical Oncology
Surgical Oncology Clinics of North America · 2022
- MERLIN_001: A prospective registry study of a primary melanoma gene-signature to predict sentinel node (SN) status and determine its prognostic value for more accurate staging of patients with SN-negative melanoma.
Journal of Clinical Oncology · 2022
- ASO Visual Abstract: Completion Lymph Node Dissection for Melanoma Before and After the Multicenter Selective Lymphadenectomy Trial-II in the USA
Annals of Surgical Oncology · 2022
- Genetic Testing and De-escalation of Contralateral Prophylactic Mastectomy
Annals of Surgical Oncology · 2021
- Annals of Surgical Oncology×11
- Obstetrics and Gynecology×5
- Fertility and Sterility×3
- Journal of Clinical Oncology×3
- Surgical Oncology Clinics of North America×2
- Doreen M. Agnese
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Ko Un Park
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Amit Agrawal
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Benjin D. Facer
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Ashley Pariser
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile